Abstract

The interaction of neutrophils with T cells has been the subject of debate and controversies. Previous studies have suggested that neutrophils may suppress or activate T cells. Despite these studies, the interaction between neutrophils and T cells has remained a largely unexplored field. Here, based on our RNA sequencing (RNA-seq) analysis, we found that neutrophils have differential transcriptional and functional profiling depending on the CD4 T-cell count of the HIV-infected individual. In particular, we identified that neutrophils in healthy individuals express surface Galectin-9 (Gal-9), which is down-regulated upon activation, and is consistently down-regulated in HIV-infected individuals. However, down-regulation of Gal-9 was associated with CD4 T-cell count of patients. Unstimulated neutrophils express high levels of surface Gal-9 that is bound to CD44, and, upon stimulation, neutrophils depalmitoylate CD44 and induce its movement out of the lipid raft. This process causes the release of Gal-9 from the surface of neutrophils. In addition, we found that neutrophil-derived exogenous Gal-9 binds to cell surface CD44 on T cells, which promotes LCK activation and subsequently enhances T-cell activation. Furthermore, this process was regulated by glycolysis and can be inhibited by interleukin (IL)-10. Together, our data reveal a novel mechanism of Gal-9 shedding from the surface of neutrophils. This could explain elevated plasma Gal-9 levels in HIV-infected individuals as an underlying mechanism of the well-characterized chronic immune activation in HIV infection. This study provides a novel role for the Gal-9 shedding from neutrophils. We anticipate that our results will spark renewed investigation into the role of neutrophils in T-cell activation in other acute and chronic conditions, as well as improved strategies for modulating Gal-9 shedding.

Highlights

  • To determine the transcriptional profile of neutrophils in HIV patients, we conducted RNA sequencing (RNA-seq) analysis on total RNA extracted from enriched neutrophils of HIVinfected individuals on antiretroviral therapy (ART), with high (>500 cells/μl) and low CD4 T-cell count (

  • In contrast to the expression of Gal-9, we found that the expression of CD32 (FCγRIIA), which can be up-regulated by cell activation [59], was significantly higher in neutrophils of HIV-infected individuals, in particular, in those with lower CD4 T-cell count compared to HCs (Fig 3K)

  • We found that neutrophils in HIV-infected individuals have an activated phenotype and shed Gal-9, which contributes to T-cell function by a newly identified mechanism

Read more

Summary

Objectives

Upon observing the differential expression of Gal-9 on neutrophils from HCs versus HIVinfected individuals (Figs 3A and 4B), we aimed to further investigate the diversity of Gal-9 expression on neutrophils in HIV-infected individuals. Upon mechanistically identifying how Gal-9 is shed from neutrophils during activation, we aimed to investigate the regulatory process contributing to the Gal-9 shedding

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call